Regenerative Medicine: Taking the Science to the Patient

The Regenerative Medicine: Taking the Science to the Patient course will run from 30 November - 1 December 2017 in Vienna, Austria THURSDAY 30 NOVEMBER 08:45 Welcome M Comer & M Fritz, Vienna & R Schmid, Berne 09:00 Keynote 1: Infarct healing as a therapeutic target Chairman: R Schmid, Berne Infarct healing as a therapeutic … Continue reading "Regenerative Medicine: Taking the Science to the Patient"
regeneration-v2

The Regenerative Medicine: Taking the Science to the Patient course will run from 30 November – 1 December 2017 in Vienna, Austria

THURSDAY 30 NOVEMBER
08:45 Welcome M Comer & M Fritz, Vienna & R Schmid, Berne
09:00 Keynote 1: Infarct healing as a therapeutic target
Chairman: R Schmid, Berne
Infarct healing as a therapeutic target KC Wollert, Hannover
09:30 Session 1: Secretome and regeneration-New kid on the block
Chairmen: J Kluin, Amsterdam & E Tschachler, Vienna
Presentations:
Secretome and regeneration: From initial to current work M Gnecchi, Pavia
Secretome-based regeneration from skin to heart HJ Ankersmit, Vienna
Secretome and MOA M Mildner, Vienna
11:00 Break
11:30 Session 2: ATMPs versus biologicals
Chairmen: M Chabicovsky, Vienna & D Niese, Freiburg
Presentations:
Safety testing of biologics and advanced therapies M Chabicovsky, Vienna
Potency assay development of drug compounds in regenerative medicine M Erb, Germany
Regulatory affairs – from science to translation T Ostler, Germany
Bringing a cellular therapy to the market: A skin to patient story D Niese, Freiburg
13:00 Lunch
14:00 Session 3: Regulatory affairs, GMP production and clinical trials
Chairmen: B Reinprecht & I Reischl, Vienna
Presentations:
Regulatory affairs – update I Reischl, Vienna
GMP production: Regulatory prerequisites A Peterbauer-Scherb, Linz
Delivering the product to the patient in a clinical trial centre U Jäger, Vienna
New regulation for ancillary/Raw materials for cell therapy K Schallmoser, Salzburg
15:30 Session 4: Adipose – derived mesenchymal stem cells in ischemic heart disease
Chairmen: T Marti, Berne & J Wojta,Vienna
Presentations:
Cell- or paracrine-mediated reparative effects in the infarct heart G Vilahur, Barcelona
Young Investigator Nominee
Young Investigator Nominee
16:30 Break and Posters
17:30 Session 5: Humans trials with ATMP secretome – from trachea, skin and valve tissue
Chairmen: M Gyongyosi & K Hoetzenecker, Vienna
Presentations:
Nerval regeneration in reconstructive therapy C Radtke, Vienna
Tracheal transplantation -current state and future aspects K Hoetzenecker, Vienna
Heart-stem cell transplantation: Reality check and future M Gyongyosi, Vienna
Valve tissue – from bench to bedside J Kluin, Amsterdam
19:00 Close
FRIDAY 1 DECEMBER
08:30 Keynote 2: Cellular plasticity and tissue regeneration
Chairmen: M Comer, Vienna & R Schmid, Berne
Keynote Presentation:
Molecular and cellular dynamics of muscle regeneration in health and disease L Puri, San Diego
Cellular plasticity and tissue regeneration: What can we learn from tumour biology T Marti, Berne
Optimisation of a human lung organoid model for lung regeneration S Hall, Berne
10:30 Break
11:00 Session 6: Inflammation and immunology
Chairmen: MB Fischer & H Stockinger, Vienna
Presentations:
Humoral immunity in the inflamed heart C Binder, Vienna
Inflammation and heart – myocarditis and AMI U Eriksson, Zurich
Young Investigator Nominee
Young Investigator Nominee
12:30  Lunch
13:30 Session 7: Micro RNAs as important regulators
Chairmen: J Grillari & H Redl, Vienna
Presentations:
Therapeutic of MSC Evs B Giebel, Essen
Correlation bone structure and miRNA plasma levels R Kocijan, Vienna
miRNA levels in a model of osteoporosis and therapy M Hackl, Vienna
Endothelial extracellular vesicles-promises and challenges C Hromada, Vienna
14:30 Session 8: Cell and gene therapy
Chairmen: D Strunk, Salzburg & T Winkler, Berlin
Presentations:
Placental stromal cells for regeneration of injured gluteal muscle after hip arthroplasty T Winkler, Berlin
Back to the future-new strategies in gene therapy C von Kalle, Heidelberg
What if we could give the body instructions to produce its own drugs? A Schneeberger, Vienna
Why we develop iPSC therapy strategies D Strunk, Salzburg
16:30 Break
17:00 Session 9: Mechano-biological aspects of cell behaviour
Chairmen: S Hall & H Redl, Vienna
Presentations:
Hippo effector protein YAP as the master regulator of cell-matrix interaction in health and disease G Forte, Brno
Mechanical stimulation by shockwave therapy induces myocardial regeneration J Holfeld, Innsbruck
The importance of mechanotransduction in myogenesis P Heher, Vienna
Effects of shockwave on adipose derived stem cells C Lindner, Vienna
Calcification of the heart valve by TLR3 J Holfeld, Innsbruck
18:30 Close

COURSE INFORMATION

Date/Duration
30 November – 1 December 2017 (2 day course)

Location
Courtyard by Marriott Prater/Messe, Trabrennstraße 4, 1020 Vienna
Click HERE for more information.

Course Directors
HJ Ankersmit, Vienna; M Comer, Vienna; T Marti, Berne; R Schmid, Berne

Course Format
Symposium

Course Fee
Industry: €250 inclusive of VAT
University representatives & Members: €150 inclusive of VAT
Students: €30 inclusive of VAT

Fee includes lunch and refreshments on 30 November and 1st December.

Target Audience
Cardio-thoracic surgeons interested in basic science, regulatory affairs involved in applied research, and the translation of ATMP- and secretome based regenerative medicine. Basic Scientists, Biologists, Biotechnologists, Residents and Fellows of all surgical specialities are most welcome.

Learning objectives
Regenerative Medicine has become the mantra of multiple innovation driven academic institutions and the nidus of multiple commercial enterprises. Academia is working on the modification and broadening of scientific insights in relation to advanced therapy medical products (ATMPs) – the technical term for “stem cell therapy” and small molecule therapy. In addition participants will learn about “paracrine factors” and their regenerative ability from in vitro to preclinical research applications. A further objective of this symposium is the description of the complex interplay between regulatory affairs and basic science in order to transfer scientific research to the patients in need.

ABSTRACTS

Click here to view the call for abstracts.

regeneration-v2

eucomedcompliant

Faculty

  • Hendrik Jan Ankersmit
  • Christoph Binder
  • Monika Chabicovsky
  • Michael Comer
  • Giancarlo Forte
  • Sean Hall
  • Johannes Holfeld
  • Bernd Giebel
  • Massimiliano Gnecchi
  • Jolanda Kluin
  • Carolin Lindner
  • Thomas Marti
  • Detlef Niese
  • Tobias Ostler
  • Mariann Pavone-Gyöngyösi
  • Anja Peterbauer-Scherb
  • Pier Lorenzo Puri
  • Heinz Redl
  • Ilona Reischl
  • Katharina Schallmoser
  • Ralph Schmid
  • Hannes Stockinger
  • Dirk Strunk
  • Gemma Vilahur
  • Christof von Kalle
  • Tobias Winkler
  • Johann Wojta
  • Kai Wollert